Determination of the Content of Dexamethasone Sodium Phosphate in the Scala Tympani Perilymph and Blood Plasma in Guinea Pigs after Intracardiac Injection of the Drug

Shun-guo ZHANG,Min-ling CHEN,Fang LI,Jun YANG,Dong-ming HOU,Hao WU
DOI: https://doi.org/10.3870/j.issn.1004-0781.2005.08.003
2005-01-01
Abstract:Objective To set up a method for the determination of the concentration of dexamethasone sodium phosphate in perilymph and blood plasma of guinea pigs. Methods HPLC was used for the determination of the content of dexamethasone sodium phosphate in the samples of perilymph and blood plasma after intracardiac injection of the drug .HPLC conditions: A ZORBAX Eclipse XDB-C_18 column (4.6 mm×250 mm,5 μm)served as the stationary phase,the mobile phase was 7.56 mmol·L~-1 ammonium sulfate- acetonitrile (70∶30) , with a flow rate of 1.0 mL·min~-1; the column temperature was 20℃, the wavelength for detection, 239 nm. Results The calibration curve of dexamethasone sodium phosphate was linear within the concentration range of 0.05-4.80 mg·L~-1(r=0.999 8), the lower limit of detection was 6.25 μg·L~-1, the intra-day and inter-days RSD were 1.7% and 2.3%. One hour after the administration of the drug, the concentrations of dexamethasone sodium phosphate were 0.08 mg·L~-1 and 2.77 mg·L~-1 in the perilymph and blood plasma ,respectively. Conclusion The method was shown to be sensitive, accurate and well reproducible ,it can thus be used for the determination of the concentration of dexamethasone sodium phosphate in perilymph and blood plasma. Our results also suggest that systemic medication of the drug is not a suitable method for the treatment of diseases of the inner ear. Other routes for the administration of the drug, therefore, should be sought.
What problem does this paper attempt to address?